< Back to latest news & events

News

IP considerations in COVID-19 vaccine development: tensions and tools

June 2020

Development of COVID-19 vaccines will produce valuable IP that could be protected by patents.

However, given that a patent application is not published until about 18 months from its initial filing date, we cannot yet see what kinds of inventions are sought to be covered, who is filing patents, and where patents are being filed to protect COVID-19 related inventions. Given the nature of the pandemic affecting most of the world’s population, its rapid spread and severe complications it causes, some may question whether any IP developed in this area should be subject to protection by private parties to begin with.

HGF Partner Dr Leena Contarino and Senior Patent Attorney Ellie Purnell discuss the perceived tension between patent protection and information sharing at a time of need for collaboration and speed, and suggest that, as evidenced by the Ebola vaccine campaign, patent protection, information sharing, and collaboration are not necessarily mutually exclusive endeavours.

They propose that while some simplified licensing schemes that could be tools to speed up sharing, such as patent pooling initiatives modelled by the telecom and electronics industry are still facing resistance among some pharma companies, development of a better information sharing platform for vaccine technologies could serve as one way to speed up collaborations at time of crises. You can read more about COVID-19 licensing challenges here.

Click here to read the full article prepared by HGF Partner Dr Leena Contarino and Senior Patent Attorney Ellie Purnell.

Latest updates

The UPC has opened its doors! See the latest updates and advice on the UPC here.

The European patent system has had the biggest change in a generation – on 1 June 2023 the Unified Patent Court (UPC) and a new “unitary patent” or “European patent …

Read article
Event - 2nd June 2023

Energy Transition Zone (ETZ) Masterclass - Demystifying Energy Transition

HGF will be attending the Energy Transition Zone (ETZ) Demystifying Energy Transition Masterclass on the 28th of June in Aberdeen. This masterclass will aim to demystify the energy transition giving …

Event details

A new dawn for European patents and patent litigation - 1 June 2023

Just as the UPC’s sunrise phase has ended, a new dawn is breaking for European patents and patent litigation.  After many years of anticipation, the Unified Patent Court (UPC) and …

Read article
Event - 29th June 2023

Dublin IP and R&D Summit

HGF are sponsors of the Dublin IP and R&D Summit on the 29th of June at the Dublin Convention Centre. Covering two days, the conference will host panels and stand-alone …

Event details

EU Draft legislation on SPCs released

On 27 April 2023 the EU published 4 draft proposals regarding SPCs. Two of these proposals are completely new and propose the creation of Unitary SPCs: COM(2023)222 for medicinal product …

Read article

Managing Intellectual Property IP Stars 2023

After months of research, Managing IP has published the IP Stars list for 2023. HGF is delighted to have 23 attorneys from England, Scotland, Ireland, Netherlands and Germany recognised and …

Read article